Henrik Mordhorst
Finanzdirektor/CFO bei SERODUS ASA
Aktive Positionen von Henrik Mordhorst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SERODUS ASA | Finanzdirektor/CFO | 01.01.2019 | - |
| HeMo ApS | Vorstandsvorsitzender | 01.09.2015 | - |
| Gründer | 01.09.2015 | - |
Karriereverlauf von Henrik Mordhorst
Ehemalige bekannte Positionen von Henrik Mordhorst
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Agrofond A/S | Vorstandsvorsitzender | 01.09.2013 | 01.08.2015 |
| Gründer | 01.09.2013 | 01.08.2015 | |
Colony Denmark ApS
 Colony Denmark ApS Packaged SoftwareTechnology Services Colony Denmark ApS provides interactive software for the television industry. Its products include Wallbreaker Platform, Pollmaker Suite, Pollbreaker, Mediamaker Suite, and Gamemaker Suite. The company was founded by Martin Kløft and Mikkel Strøbech in 2014 and is headquartered in Copenhagen, Denmark. | Direktor/Vorstandsmitglied | - | - |
| Finanzdirektor/CFO | - | - |
Ausbildung von Henrik Mordhorst
| Copenhagen Business School | Graduate Degree |
Statistik
International
| Dänemark | 5 |
| Norwegen | 2 |
Operativ
| Director of Finance/CFO | 2 |
| Chief Executive Officer | 2 |
| Founder | 2 |
Sektoral
| Technology Services | 2 |
| Health Technology | 2 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Colony Denmark ApS
Colony Denmark ApS Packaged SoftwareTechnology Services Colony Denmark ApS provides interactive software for the television industry. Its products include Wallbreaker Platform, Pollmaker Suite, Pollbreaker, Mediamaker Suite, and Gamemaker Suite. The company was founded by Martin Kløft and Mikkel Strøbech in 2014 and is headquartered in Copenhagen, Denmark. | Technology Services |
Serodus ASA
 Serodus ASA BiotechnologyHealth Technology Serodus ASA is a bio-medical company, which engages in the development of medicines for the treatment of diabetes related complications. It focuses on diabetic kidney disease, diabetic retinopathy, type 1 diabetes, and diabetic foot ulcers. The company was founded by Finn Olav Levy on January 21, 2008 and is headquartered in Oslo, Norway. | Health Technology |
| Agrofond A/S | |
| HeMo ApS |
- Börse
- Insiders
- Henrik Mordhorst
- Erfahrung
